EuroGRAFT
Action number CA17138 COST

Our
People

The main aim and objective of the Action is to establish a European Network to further understand chronic GvHD, through networking and interdisciplinary training.

People & Profiles

Chair & Vice Chair

  • Prof. Anne Dickinson

    Prof. Anne Dickinson

    Professor Anne Dickinson is a Strategic Research Advisor in Haematological Sciences, Institute of Cellular Medicine, Newcastle University, UK. Her teaching and research focuses on non-HLA immunogenetics in haematopoietic stem cell transplantation, and the immunopathology of graft-versus-host disease (GvHD). She is a Health Professions Council registered Clinical Scientist and has over 25 years experience in manipulation of haematopoietic stem cells for clinical use, and more recently in HTA audit and MHRA license procedures. In 2008, she founded Alcyomics Ltd based on 20 years experience with a human in vitro skin explant model for predicting GvHD, which is now used to predict allergy and sensitisation to chemicals and  therapeutic monoclonal antibodies and drugs.

  • Prof. Hildegard Greinix

Action Science Officer

Dr Deniz KARACA
Science officer
+3225333831

Visit the COST website for more information

WG Leaders

  • Daniel Wolff

  • Magdalena Grce

  • Robert Zeiser

  • Atillio Olivieri

    Atillio Olivieri

    Attilio Olivieri is an expert in stem cell transplantation fields and in techniques employed in the cell processing, purging and cryopreservation. He has been Chairman of the Italian group for Transplantation (GITMO) for GVHD management since 2015 and has been involved as a member of the NIH Board for the new Consensus Conference on cGVHD.

  • Prof Marit Inngjerdingen

  • Dr Hélène Schoemans

    Dr Hélène Schoemans

    Helene has been employed at the UZ Leuven (Belgium) since 2009 as a bone marrow transplantation physician. Her particular interests are Graft versus host disease, Survivorship, Patient Reported Outcomes, eHealth, Chronic care models and Quality of life. She is Chair of the ‘Late Effects Subcommittee’ of the Transplant Complications Working Party of the EBMT (European Society for Bone & Marrow Transplantation).

  • Drazen Pulanic

    Drazen Pulanic

    Dr Pulanic is a specialist of Internal Medicine and Subspecialist in Hematology in the department of Internal Medicine, University Hospital Center Zagreb and Medical School University of Zagreb, Croatia.

  • Ulrike Koehl

Management Positions (STSM & Science Comm Managers)

  • Dr Hajnalka Andrikovics

  • Prof Katarzyna Bogunia-Kubik

  • Dr Rachel Crossland

MC Members

  • Dr Anita Lawitschka

  • Prof. Hildegard Greinix

  • Dr Hélène Schoemans

    Dr Hélène Schoemans

    Helene has been employed at the UZ Leuven (Belgium) since 2009 as a bone marrow transplantation physician. Her particular interests are Graft versus host disease, Survivorship, Patient Reported Outcomes, eHealth, Chronic care models and Quality of life. She is Chair of the ‘Late Effects Subcommittee’ of the Transplant Complications Working Party of the EBMT (European Society for Bone & Marrow Transplantation).

  • Mr Josip Petrovic

  • Dr Maya Yordanova

  • Prof Milena Ivanova-Shivarova

    Prof Milena Ivanova-Shivarova

    Professor in Immunology at Medical University Sofia and a Head of Tissue typing laboratory in Clinical Immunology, University Hospital Alexandrovska, Sofia, Bulgaria. Her research interests and experience include Immunogenetics, Transplant immunology (biomarkers HSCT outcome), genetic testing for mutations, analysis on immunogenetic factors.

  • Drazen Pulanic

    Drazen Pulanic

    Dr Pulanic is a specialist of Internal Medicine and Subspecialist in Hematology in the department of Internal Medicine, University Hospital Center Zagreb and Medical School University of Zagreb, Croatia.

  • Magdalena Grce

  • Prof Jukka Partanen

  • Prof Gerard Socie

    Prof Gerard Socie

    Prof Socie is Head of Hematology/Transplantation at Hospital Saint Louis Paris. His main field of expertise is allogeneic stem cell transplantation with special focus on graft-versus-host disease and study of late effects, aplastic anemia with special focus on PNH, and Fanconi anemia.

  • Daniel Wolff

  • Ulrike Koehl

  • Dr Hajnalka Andrikovics

  • Dr Miklós László Udvardy

  • Prof Chiara Bonini

  • Prof Sara Galimberti

  • Prof Lisbet Sviland

  • Prof Marit Inngjerdingen

  • Prof Katarzyna Bogunia-Kubik

  • Dr Jose Silvestre Serra Da Silva

    Dr Jose Silvestre Serra Da Silva

    Assistant Professor of the Exact Sciences and Engineering Department of the Portuguese Military Academy. His interests are in areas of Pattern Recognition, Multi-Spectral Image Fusion and Medical Image Processing.

  • Dr Vladimir Perovic

  • Dr Rachel Crossland

  • Dr Jörg Halter

  • Dr Xiao-Nong Wang

  • Antonio Pérez Martínez

    Antonio Pérez Martínez

    Head of the Paediatric Haemato-Oncology and Haematopoietic Transplant Service of the La Paz University Hospital in Madrid. Research interests and expertise include paediatric allogeneic stem cell transplantation, graft engineering, cell therapy and management of complications. Specialist in paediatric cancer immunotherapy focused on adoptive immunotherapy with NK cells and memory T cells (45RA-) as well as in the field of Advanced Therapy Drugs (ATMPs) such as activated and expanded Natural Killer lymphocytes (NKAE) and T / T memory lymphocytes with Chimeric Antigen Receptor (CAR-T/CAR-NK)​.

  • Dr Philippe Lewalle

    Dr Philippe Lewalle

    Philippe Lewalle MD, PhD leads the allogeneic stem cell program at the Jules Bordet Institute, Université Libre de Bruxelles (ULB). As director of the Cellular Therapy and GMP Cell Processing facilities, he is responsible of hematopoietic stem cells, antigen-specific lymphocytes, dendritic cells and mesenchymal stem cells production and banking. Doctor Lewalle attended medical school at the Université Catholique de Louvain (UCL). He subsequently trained in Internal Medecine and Hematology. This was followed by a research fellowship at the NHLBI, NIH Bethesda, in the Laboratory of Allogeneic Stem Cell Transplantation where he developed an interest in immunotherapy and graft versus leukaemia reactions in CML and AML. In 1996 he moved to the Jules Bordet Institute to continue his work in both the clinic and the laboratory. In recent years he has developed an interest in haploidentical stem cell transplantation. All his research goal have a clinical focus with a particular emphasis on the development of active or adoptive immunotherapy by translation of basic science into appropriate clinical protocols. Long-term objective include the identification of biomarkers of the leukaemia immune microenvironnement and markers predictive of immunotherapy response.

  • Dr Nuala Mooney

  • Dr Anna Barata

  • Dr Eric Tkaczyk

    Dr Eric Tkaczyk

    Dr Tkaczyk is a physician-scientist with research interests in biophotonics for diagnosis and treatment of skin diseases. He is a graduate of the MD/PhD at the University of Michigan, with a PhD in electrical engineering from the Center for Ultrafast Optical Science (CUOS). He is Assistant Professor of Dermatology and Biomedical Engineering at Vanderbilt University Medical Center and lectures internationally on dermatologic imaging technologies, which is his research focus. A major focus is the development and clinical investigation of noninvasive methods to assess graft-versus-host disease (GVHD) in bone marrow / hematopoietic stem cell transplantation (HCT) patients.

  • Amira Ćerimagić

    Amira Ćerimagić

    I am a young teaching and research assistant at the Department of Medical Biochemistry at the Medical Faculty University of Sarajevo, Bosnia and Herzegovina. I am also a resident in Clinical Immunology which I perform at the University Clinical Center of Sarajevo. As a future Clinical Immunologist the fields of Transplantation Immunology and GVHD are a must to master and a frequent problem in the everyday practical works of a Clinical Immunologist.

MC Substitutes

  • Dr Satu Koskela

  • Prof Gabriele Multhoff

  • Prof Frode Jahnsen

  • Dr Emina Milosevic

  • Dr Shaheda Ahmed

  • Dr Alexander Deutsch

  • Robert Zeiser

  • Atillio Olivieri

    Atillio Olivieri

    Attilio Olivieri is an expert in stem cell transplantation fields and in techniques employed in the cell processing, purging and cryopreservation. He has been Chairman of the Italian group for Transplantation (GITMO) for GVHD management since 2015 and has been involved as a member of the NIH Board for the new Consensus Conference on cGVHD.

  • Prof Jakob R. Passweg

See Also

Find out more about the Action by exploring the site links on the right hand side.

Are you interested
in taking part?

The COST Action EUROGRAFT welcomes research-active scientists working in the field. There are many ways to get involved.

Get involved

Get involved

Do you have a question?

If you have any questions or would like to know more about the project, simply connect with us and we’ll be happy to talk to you.